<?xml version="1.0" encoding="UTF-8"?>
<NDC>
<NDCCode>
60846-701-50
</NDCCode>
<PackageDescription>
50 g in 1 JAR (60846-701-50)
</PackageDescription>
<NDC11Code>
60846-0701-50
</NDC11Code>
<ProductNDC>
60846-701
</ProductNDC>
<ProductTypeName>
HUMAN PRESCRIPTION DRUG
</ProductTypeName>
<ProprietaryName>
Lidocaine
</ProprietaryName>
<ProprietaryNameSuffix/>
<NonProprietaryName>
Lidocaine
</NonProprietaryName>
<DosageFormName>
OINTMENT
</DosageFormName>
<RouteName>
TOPICAL
</RouteName>
<StartMarketingDate>
20160311
</StartMarketingDate>
<EndMarketingDate>
20181130
</EndMarketingDate>
<MarketingCategoryName>
ANDA
</MarketingCategoryName>
<ApplicationNumber>
ANDA206297
</ApplicationNumber>
<LabelerName>
Gemini Laboratories, Inc.
</LabelerName>
<SubstanceName>
LIDOCAINE
</SubstanceName>
<StrengthNumber>
50
</StrengthNumber>
<StrengthUnit>
mg/g
</StrengthUnit>
<Pharm_Classes>
Amide Local Anesthetic [EPC],Amides [Chemical/Ingredient],Antiarrhythmic [EPC],Local Anesthesia [PE]
</Pharm_Classes>
<DEASchedule/>
<Status>
Deprecated
</Status>
<LastUpdate>
2018-12-02
</LastUpdate>
<PackageNdcExcludeFlag>
N
</PackageNdcExcludeFlag>
<ProductNdcExcludeFlag>
N
</ProductNdcExcludeFlag>
<ListingRecordCertifiedThrough/>
<StartMarketingDatePackage/>
<EndMarketingDatePackage/>
<SamplePackage/>
</NDC>